These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34256099)

  • 1. Potential pharmacokinetic interaction between orally administered drug and osmotically active excipients in pediatric polypharmacy.
    Matsui K; Nakagawa T; Okumura T; Yamane M; Tokunaga Y; Yokota S
    Eur J Pharm Sci; 2021 Oct; 165():105934. PubMed ID: 34256099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Provisional No-Effect Threshold of Sugar Alcohols on Oral Drug Absorption Estimated by Physiologically Based Biopharmaceutics Model.
    Yamane M; Matsui K; Sugihara M; Tokunaga Y
    J Pharm Sci; 2021 Jan; 110(1):467-477. PubMed ID: 32470348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of sorbitol as pharmaceutical excipient in the present day formulations - issues and challenges for drug absorption and bioavailability.
    Dash RP; Srinivas NR; Babu RJ
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1421-1429. PubMed ID: 31271324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: impact on bioequivalence.
    García-Arieta A
    Eur J Pharm Sci; 2014 Dec; 65():89-97. PubMed ID: 25236823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biowaiver monographs for immediate release solid oral dosage forms: lamivudine.
    Strauch S; Jantratid E; Dressman JB; Junginger HE; Kopp S; Midha KK; Shah VP; Stavchansky S; Barends DM
    J Pharm Sci; 2011 Jun; 100(6):2054-63. PubMed ID: 21491435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excipient pharmacokinetics and profiling.
    Loftsson T
    Int J Pharm; 2015 Mar; 480(1-2):48-54. PubMed ID: 25596414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.
    Debotton N; Dahan A
    Med Res Rev; 2017 Jan; 37(1):52-97. PubMed ID: 27502146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric drug development: formulation considerations.
    Ali AA; Charoo NA; Abdallah DB
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excipients in medicinal products used in gastroenterology as a possible cause of side effects.
    Ursino MG; Poluzzi E; Caramella C; De Ponti F
    Regul Toxicol Pharmacol; 2011 Jun; 60(1):93-105. PubMed ID: 21354240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excipient Stability in Oral Solid Dosage Forms: A Review.
    Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
    AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some factors influencing the bioavailability of zinc in oral pharmaceutical dosage forms].
    Neve J; Hanocq M; Peretz A; Abi Khalil F; Pelen F
    J Pharm Belg; 1993; 48(1):5-11. PubMed ID: 8483101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Metformin Hydrochloride.
    Metry M; Shu Y; Abrahamsson B; Cristofoletti R; Dressman JB; Groot DW; Parr A; Langguth P; Shah VP; Tajiri T; Mehta MU; Polli JE
    J Pharm Sci; 2021 Apr; 110(4):1513-1526. PubMed ID: 33450218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V; Musakhanian J; Marchaud D
    Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.
    Walsh J; Cram A; Woertz K; Breitkreutz J; Winzenburg G; Turner R; Tuleu C;
    Adv Drug Deliv Rev; 2014 Jun; 73():14-33. PubMed ID: 24614069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
    Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Physiologically Based Pharmacokinetic (PBPK) Modeling to Evaluate the Impact of Pharmaceutical Excipients on Oral Drug Absorption: Sensitivity Analyses.
    Chow EC; Talattof A; Tsakalozou E; Fan J; Zhao L; Zhang X
    AAPS J; 2016 Nov; 18(6):1500-1511. PubMed ID: 27520379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients.
    Ilie AR; Griffin BT; Vertzoni M; Kuentz M; Cuyckens F; Wuyts K; Kolakovic R; Holm R
    Drug Dev Ind Pharm; 2020 Dec; 46(12):2051-2060. PubMed ID: 33124918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal effects of sorbitol as an additive in liquid medications.
    Johnston KR; Govel LA; Andritz MH
    Am J Med; 1994 Aug; 97(2):185-91. PubMed ID: 8059785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.